Pfizer Inc. said Friday the U.S. Food and Drug Administration has approved its migraine nasal spray Zavzpret. The treatment is the first and only calcitonin...
Pfizer Inc. PFE said Friday the U.S. Food and Drug Administration has approved its migraine nasal spray Zavzpret. The treatment is the first and only calcitonin gene-related peptide receptor antagonist nasal spray that treats acute migraine in adults, the company said in a statement. A Phase 3 study of Zavzpret found it was statistically superior to placebo on both primary endpoints of pain freedom and freedom from most symptoms at two hours after a dose.
Food and Drug Administration has approved its migraine nasal spray Zavzpret. The treatment is the first and only calcitonin gene-related peptide receptor antagonist nasal spray that treats acute migraine in adults, the company said in a statement. A Phase 3 study of Zavzpret found it was statistically superior to placebo on both primary endpoints of pain freedom and freedom from most symptoms at two hours after a dose.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Pactiv Evergreen, Inc. leaving 160 without jobsPactiv Evergreen, Inc. announced Monday that they would be closing their Olmsted Falls facilities, according to a Facebook Post from the City of Olmstead Falls.
Consulte Mais informação »
Girls Inc. and Zonta Club celebrate International Women’s DayGirls Incorporated of Dothan is bringing the global celebration here by helping women inspire and uplift each other.
Consulte Mais informação »
Disinformation Inc: Ken Buck presses State Department on grants to conservative blacklist group.RepKenBuck is pressing StateDept for answers over it funding the DisinfoIndex, a group dcexaminer revealed is feeding conservative website blacklists to advertising companies. Buck said that this censorship by foreign entities is 'troubling'.
Consulte Mais informação »
FDA Approves Amphastar Pharma's Nasal Spray for Opioid OverdoseAmphastar Pharmaceuticals Inc said on Wednesday the FDA had approved its nasal spray for emergency treatment of known or suspected opioid overdose.
Consulte Mais informação »
Albuterol Shortage Challenges Hospitals Treating Patients With Breathing ProblemsHospitals are running out of a liquid form of albuterol, a medication used to treat people with breathing problems, weeks after the only maker of the product declared bankruptcy
Consulte Mais informação »
FDA Extends Review of BioMarin's Bleeding Disorder TherapyThe Food and Drug Administration has extended the review of BioMarin Pharmaceutical's experimental gene therapy for adults with a severe bleeding disorder, the latest delay in the company's quest to gain approval in the country.
Consulte Mais informação »